# A Study of Auxora in Patients With Severe COVID-19 Pneumonia

> **NCT04345614** · PHASE2 · COMPLETED · sponsor: **CalciMedica, Inc.** · enrollment: 314 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Auxora (Part 1)
- **DRUG:** Standard of Care (Part 1)
- **DRUG:** Auxora (Part 2)
- **DRUG:** Placebo (Part 2)

## Key facts

- **NCT ID:** NCT04345614
- **Lead sponsor:** CalciMedica, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-08
- **Primary completion:** 2021-06-28
- **Final completion:** 2021-07-30
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345614, "A Study of Auxora in Patients With Severe COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04345614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*